Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome

Clinical trial NCT00309257 · COMPLETED

Trial details

NCT number: NCT00309257
Sponsor: Mario Negri Institute for Pharmacological Research
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alport Syndrome

Start date: 2004-01-01
Primary completion: 2008-06-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.